4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)methyl)morpholine, 95.0%, 1g

2-(3,4-Dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100g

Tri-n-octylamine>97.0%(GC)(T)100mL

(6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate, 98%, 5g

4,4'-Dimethoxytrityl chloride, min 98%, for synthesis, 25 g, glass packaging

ISOACTEOSIDE, 98%, 1g

4-Ethyl-3-nitrobenzoic acid, 95.0%, 5g

2-Iodo-1-methoxy-3-methyl-5-(trifluoromethyl)benzene, 98%, 100mg

8-Oxa-2-azaspiro[4.5]decan-3-one, 95.0%, 1g

(3-((4-Cyanophenyl)carbamoyl)phenyl)boronic acid, 95%, 5g

7-Octynylamine (7CI,8CI), 98%, 5g

N-(2-Cyano-3-fluorophenyl)acetamide, 97%, 100mg

4H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one, 97%, 50mg